Paratus Appoints Alicia Secor as President and Chief Executive Officer; Expands Leadership Team to Support Next Phase of Growth
Paratus Sciences Presents Preclinical and Translational Data on PS-1001, a First-in-Class Pan-Inflammasome Inhibitor, at FOCIS 2026
